Literature DB >> 24747679

Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma.

Alvaro Sanz Rubiales1, Virginia de la Cruz2, José Ángel Berezo3, María Ángeles Torres4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24747679     DOI： 10.1016/j.jpainsymman.2013.12.248

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN： 0885-3924            Impact factor:   3.612


× No keyword cloud information.
  2 in total

1.  Favorable response to pemetrexed, cisplatin and bevacizumab in invasive mucinous adenocarcinoma: A case report and literature review.

Authors:  Xian Wen Sun; Yong Jie Ding; Yu Yan Zhang; Pei Li Chen; Ya Ru Yan; Ji Min Shen; Qing Yun Li
Journal:  Mol Clin Oncol       Date:  2018-06-11

2.  Bronchorrhea, a Rare and Debilitating Symptom of Lung Cancer: Case Report and Review of the Treatment.

Authors:  Milind Bhagat; Aditi Singh; Talal Bazzi; Jason Green
Journal:  JTO Clin Res Rep       Date:  2022-08-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.